Imperial Ginseng Products Ltd.
IGPFF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 24.9% | -52.1% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | – | 1.2% | -6% | 2.5% |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | – | 97.2% | 92.7% | -74.1% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | – | 67.8% | 67.3% | -62.3% |
| EPS Diluted | 0.027 | 0.38 | 0.31 | -0.61 |
| % Growth | -92.8% | 22.6% | 150.8% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |